Skip to content
Cao Lab
  • Current Research
    • What is Progeria?
    • Publications
    • Latest News from the Cao Lab
  • Contact
  • Meet The Team
Menu Close
  • Current Research
    • What is Progeria?
    • Publications
    • Latest News from the Cao Lab
  • Contact
  • Meet The Team

A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model.

  • Post author:caolab75@gmail.com
  • Post published:August 15, 2008
  • Post category:Articles
15902.full_

You Might Also Like

In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice

January 6, 2021

Mechanisms of genome instability in Hutchinson-Gilford progeria

November 10, 2016

Cellular Basis of Laminopathies

July 16, 2012
Cao Lab

My laboratory would like to further examine the causative relationship between progerin production and the aging process, to study the regulation of progerin production in normal cells, and to determine the contribution of progerin in normal human aging.

  • What is Progeria?Opens in a new tab
  • Current ResearchOpens in a new tab
  • PublicationsOpens in a new tab
  • Meet The TeamOpens in a new tab
  • MBlue LabsOpens in a new tab
  • 2219 Bioscience Research Building
  • 301-405-3408
  • Email UsOpens in your application